In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...

GSK (GSK), a large British drug maker, is rallying 8% after reporting higher-than-expected fourth-quarter earnings per share and raising its long-term revenue guidance. Last quarter, its operating ...

Q4 2024 dividend of 16p declared; 61p FY 2024; 64p expected for 2025. GSK (GSK) now intends to commence a GBP 2B share buyback programme, to be implemented over the next 18 months. Published first ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.40. The company’s shares opened today ...

GSK said it now e American depositary shares of GSK jumped more than 8% Wednesday after the drugmaker reported better-than-expected quarterly results and boosted its long-term sales forecast.

It adds that for the healthcare sector to grow, the future workforce will need to embrace artificial intelligence. Sabrina Ng speaks to its CEO to find out what the future of healthcare looks like.

Days into his return to power, however, reactions from some voters highlight how difficult it could be for Trump to maintain his populist appeal alongside his embrace of fellow billionaires as ...

Commissions do not affect our editors' opinions or evaluations. We like Embrace’s Healthy Pet Discount Program as a unique way to save on an accident and illness policy. If your claim ...

North Korea, Afghanistan and Belarus are some of the countries considered to be rulef by hard autocratic regimes (Picture: AP/AFP/GETTY) Generation Z is prepared to embrace a dictatorship in ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines. The University of Oxford and GSK are to work on a vaccine to target cells in the ...

For the past 25 years, the NFL’s approach to expanding the replay-review process has gone like this: Wait for a non-reviewable situation to create a controversy, and then expand replay to cover it in ...